NGM·Healthcare·$545M·#180 / 520 in Healthcare
CERS Cerus Corporation
55SPECULATIVE
CATEGORY BREAKDOWN
GROWTH23
QUALITY60
STABILITY67
VALUATION92
GOVERNANCE42
METRIC BREAKDOWN
Revenue Growth (YoY)
Year-over-year revenue growth rate
+14.3%
23
> 50% strong
Gross Margin
Revenue retained after direct costs
54.5%
77
> 50% strong
Cash Runway
Months of cash at current burn rate
999 months
100
> 24 months ideal
Debt / Equity
Total debt relative to shareholder equity
150.9%
0
< 25% strong
Price / Sales
Market cap relative to trailing revenue
2.5x
92
< 3x strong
Rule of 40
Growth rate plus operating margin
10
35
> 40 excellent
Insider Ownership
Percentage of shares held by insiders
3.3%
26
> 20% strong
Share Dilution (12M)
Share count increase over last 12 months
+4.6%
73
< 5% ideal
SCORE HISTORY
RELATED STOCKS
COMPARE CERS WITH…
OR QUICK-COMPARE SECTOR PEERS
SCORE ALERT
Get notified when CERS's score changes by 5+ points.
DATA INFO
Last updated: May 4, 2026
Sources: SEC EDGAR, Financial Modeling Prep, Yahoo Finance. Not financial advice.